Cargando…

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives

Toll-like receptors (TLRs) serve as the body’s first line of defense, recognizing both pathogen-expressed molecules and host-derived molecules released from damaged or dying cells. The wide distribution of different cell types, ranging from epithelial to immune cells, highlights the crucial roles of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Suprabhat, Patra, Ritwik, Behzadi, Payam, Masotti, Andrea, Paolini, Alessandro, Sarshar, Meysam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562563/ https://www.ncbi.nlm.nih.gov/pubmed/37822929 http://dx.doi.org/10.3389/fimmu.2023.1244345

Ejemplares similares

FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens
por: Sarshar, Meysam, et al.
Publicado: (2020)

Toll-like receptor 4 in COVID-19: friend or foe?
por: Mukherjee, Suprabhat
Publicado: (2022)

The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)
por: Behzadi, Elham, et al.
Publicado: (2016)

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
por: Behzadi, Payam, et al.
Publicado: (2022)

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach
por: Patra, Ritwik, et al.
Publicado: (2021)

Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma
por: Patra, Ritwik, et al.
Publicado: (2023)

Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen
por: Sarshar, Meysam, et al.
Publicado: (2021)

Toll-Like Receptors: General Molecular and Structural Biology
por: Behzadi, Payam, et al.
Publicado: (2021)

Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach
por: Padma, Somrita, et al.
Publicado: (2023)

Biomarkers to Monitor Adherence to Gluten-Free Diet by Celiac Disease Patients: Gluten Immunogenic Peptides and Urinary miRNAs
por: Paolini, Alessandro, et al.
Publicado: (2022)

Editorial: Uropathogens, urinary tract infections, the host-pathogen interactions and treatment
por: Behzadi, Payam, et al.
Publicado: (2023)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Improving the Diagnostic Potential of Extracellular miRNAs Coupled to Multiomics Data by Exploiting the Power of Artificial Intelligence
por: Paolini, Alessandro, et al.
Publicado: (2022)

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein
por: Das, Nabarun Chandra, et al.
Publicado: (2022)

Editorial: Transplantation of Marginal Organs—Immunological Aspects and Therapeutic Perspectives
por: Süsal, Caner, et al.
Publicado: (2020)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Gene loss and co-option of toll-like receptors facilitate paternal immunological adaptation in the brood pouch of pregnant male seahorses
por: Zhang, Bo, et al.
Publicado: (2023)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
por: Kumar, Sudeep, et al.
Publicado: (2019)

Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2020)

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

Computational Insight Into the Structural Organization of Full-Length Toll-Like Receptor 4 Dimer in a Model Phospholipid Bilayer
por: Patra, Mahesh Chandra, et al.
Publicado: (2018)

Toll-Like Receptors of Deuterostome Invertebrates
por: Satake, Honoo, et al.
Publicado: (2012)

Toll-Like Receptors and Skin Cancer
por: Burns, Erin M., et al.
Publicado: (2014)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)

Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions
por: Sarshar, Meysam, et al.
Publicado: (2020)

The Acinetobacter baumannii model can explain the role of small non-coding RNAs as potential mediators of host-pathogen interactions
por: Sarshar, Meysam, et al.
Publicado: (2022)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex
por: Lembo-Fazio, Luigi, et al.
Publicado: (2018)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

The Role of Toll-Like Receptors in Hematopoietic Malignancies
por: Monlish, Darlene A., et al.
Publicado: (2016)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
por: Savva, Athina, et al.
Publicado: (2013)

Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation
por: Souza, Pedro P. C., et al.
Publicado: (2019)

Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia
por: Matarazzo, Laura, et al.
Publicado: (2019)

Toll-Like Receptors as Modulators of Mesenchymal Stem Cells
por: DelaRosa, Olga, et al.
Publicado: (2012)

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy
por: Awasthi, Shanjana
Publicado: (2014)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

Toll-Like Receptor Activation in Immunity vs. Tolerance
por: Filippi, Christophe M.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0p6rprje1lpslfgu2nclfo3olu